Fig. 1. Flowchart breakdown of included and excluded articles.
Table 2. Population, intervention (Oxandrolone) characteristics of the included studies (n = 24).
Fig. 2. Population (children/adolescents and adults/older adults) with main reported outcomes for specific diseases.
Table 3. Intervention (Oxandrolone) characteristics of the included studies (n = 24).
Fig. 3. Percentage of adverse events reported with the use of oxandrolone in comparison to placebo.
Supplemental 1. Articles excluded and the reasons for exclusion (n = 33).
my experience with low dose vs high dose primobolan
masteron vs proviron: which is better for muscle hardness
my experience with low dose vs high dose primobolan
Latest Post: Nandrolone Phenylpropionate vs Decanoate (DECA) Benefits Our newest member: Josh Sutton Recent Posts Unread Posts
